Trial data at the 2 mg/week dose (lower end of Phase 2) ran somewhat below the 4 mg+ doses
The research highlights a pivot toward healthier lifestyles among GLP-1 users, driven by a 41-point increase in weight management being cited as their primary health goal since 2021
Ideal for Active LifestylesPerfect for athletes, fitness enthusiasts, and anyone on a calorie-restricted diet seeking to maximise fat utilisation
And some that look promising today will fail for reasons that have nothing to do with efficacy
CP nephrotoxicity may result in a wide range of manifestations including distal renal tubular acidosis, chronic kidney disease (CKD), defect in urinary concentrating ability, thrombotic microangiopathy, transient proteinuria, glucosuria, hyperuricemia, hypocalcemia, and other electrolyte imbalances, most importantly magnesium and potassium losses (Miller et al., 2010
This test maps 14 distinct metabolic pathways and 49 peptides to identify which GLP-1 formulation may work most effectively for your unique biology